High‐dose vitamin D supplementation in patients with severe acute respiratory syndrome coronavirus 2 pneumonia hospitalized in a polyvalent intensive care unit: A retrospective cohort study
Nutrition in Clinical Practice · 2025
DOI: 10.1002/ncp.11277 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Nutrition in Clinical Practice, 2025. Verfasst von Mafalda Vasconcelos und 2 weiteren Autor:innen. Beteiligte Einrichtung: Serviço de Medicina Interna, Hospital Beatriz Ângelo, Loures, Portugal. Hauptthemen laut MEDLINE: Vitamin D, Intensive Care Units, COVID-19, Dietary Supplements. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: This research did not receive any specific grant funding agencies in the public, commercial, or not-for-profit sectors..
Themen: Intensivpflege
Abstract (Originalsprache)
Background and Aims The health benefits of vitamin D are far beyond bone mineral metabolism. Vitamin D has immunomodulator and anti‐inflammatory properties and its role in critically ill patients is controversial. The purpose of the study is to understand whether high doses of vitamin D supplementation are beneficial in patients with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pneumonia hospitalized in a polyvalent intensive care unit (ICU) and correlate to all‐cause mortality, need for invasive mechanical ventilation, and duration of hospitalization.
Methods
A retrospective study was conducted at a single polyvalent ICU, comparing patients supplemented with vitamin D with nonsupplemented patients. Eligible participants were adults with SARS‐CoV‐2 pneumonia admitted in this unit between April 14, 2020, and October 31, 2020. Demographic and clinical characteristics, comorbidities, and disease‐related outcomes were extracted from electronic medical records.
Results
No statistically significant differences were observed between the groups in terms of need for invasive mechanical ventilation or duration of hospitalization. Supplementation with vitamin D was associated with lower all‐cause ICU, intrahospital, and total mortality.
Conclusion
High‐dose vitamin D supplementation was associated with a reduction of mortality in patients with severe SARS‐CoV‐2 pneumonia. Randomized clinical trials are needed to confirm these findings and to assess the optimal dosage of supplementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Serviço de Medicina Interna, Hospital Beatriz Ângelo, Loures, Portugal.
- Serviço de Medicina Intensiva, Hospital Beatriz Ângelo, Loures, Portugal.
Förderung
- This research did not receive any specific grant funding agencies in the public, commercial, or not-for-profit sectors.
Zitieren
APA
Vasconcelos, M., Rodrigues, B. S., & Gonçalves, A. (2025). High‐dose vitamin D supplementation in patients with severe acute respiratory syndrome coronavirus 2 pneumonia hospitalized in a polyvalent intensive care unit: A retrospective cohort study. Nutrition in Clinical Practice. https://doi.org/10.1002/ncp.11277
Vancouver
Vasconcelos M, Rodrigues BS, Gonçalves A. High‐dose vitamin D supplementation in patients with severe acute respiratory syndrome coronavirus 2 pneumonia hospitalized in a polyvalent intensive care unit: A retrospective cohort study. Nutrition in Clinical Practice. 2025. doi:10.1002/ncp.11277
BibTeX
@article{Vasconcelos2025,
author = {Vasconcelos, Mafalda and Rodrigues, Bárbara Sucena and Gonçalves, Ana},
title = {High‐dose vitamin D supplementation in patients with severe acute respiratory syndrome coronavirus 2 pneumonia hospitalized in a polyvalent intensive care unit: A retrospective cohort study},
journal = {Nutrition in Clinical Practice},
year = {2025},
doi = {10.1002/ncp.11277}
}
EUVIMED